NovoCure Limited (NVCR) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $22.15, up from yesterday’s close by 3.02%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
NovoCure Limited (NVCR) currently trades with a market capitalization of $1.94 Billion. That value represents a market adjusting for revenues that have been growing by 131.19 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$53.57 Million over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of -$0.11 on a per share basis this quarter. Perhaps, that suggests something about why 8.78% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how NVCR has been acting. Looking at the stock’s movement on the chart, NovoCure Limited recorded a 52-week high of $22.30. It is now trading 0.15% off that level. The stock is trading $19.86 its 50-day moving average by -2.29%. The stock carved out a 52-week low down at $6.00.
In recent action, NovoCure Limited (NVCR) has made a move of +8.05% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 21.04, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 5.62% with $68.73 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of NVCR.